Assignee
IMPRIMIS PHARMACEUTICALS INC
US·8 granted patents·22 pending applications·33 citations·filing 2014–2018
Top patents by PatentIndex Score
30 records- 0191US9918993B2Pharmaceutical compositions for anesthesiological applicationsIMPRIMIS PHARMACEUTICALS INC·Filed 2016·Granted Mar 20, 2018·9 cites·21 claims
- 0281US10383875B2Pharmaceutical formulations of xanthine or xanthine derivatives, and their useIMPRIMIS PHARMACEUTICALS INC·Filed 2017·Granted Aug 20, 2019·4 cites·23 claims
- 0380US10285957B2Epinephrine-based ophthalmic compositions for intraocular administration and methods for fabricating thereofIMPRIMIS PHARMACEUTICALS INC·Filed 2017·Granted May 14, 2019·4 cites·18 claims
- 0480US9301936B2Pharmaceutical formulations of tranexamic acid and their useIMPRIMIS PHARMACEUTICALS INC·Filed 2014·Granted Apr 5, 2016·8 cites·39 claims
- 0579US10166240B2Pharmaceutical compositions and methods for anesthesiological applicationsIMPRIMIS PHARMACEUTICALS INC·Filed 2018·Granted Jan 1, 2019·3 cites·19 claims
- 0677US10179136B2Pharmaceutical compositions and methods for anesthesiological applicationsIMPRIMIS PHARMACEUTICALS INC·Filed 2018·Granted Jan 15, 2019·1 cites·23 claims
- 0773US9849133B2Pharmaceutical formulations of xanthine or xanthine derivatives, and their useIMPRIMIS PHARMACEUTICALS INC·Filed 2014·Granted Dec 26, 2017·4 cites·12 claims
- 0854US2017326161A1Pharmaceutical formulations for treating skin disorders and methods for fabricating and using thereofIMPRIMIS PHARMACEUTICALS INC·Filed 2017·Application pending·0 cites
- 0952US2016354308A1Epinephrine-based ophthalmic compositions for intraocular administration and methods for fabricating thereofIMPRIMIS PHARMACEUTICALS INC·Filed 2016·Application pending·0 cites
- 1050US2016279055A1Pharmaceutical ophthalmic compositions for intraocular administration and methods for fabricating thereofIMPRIMIS PHARMACEUTICALS INC·Filed 2016·Application pending·0 cites
- 1148US2015335704A1Pharmaceutical compositions comprising gels and methods for fabricating thereofIMPRIMIS PHARMACEUTICALS INC·Filed 2015·Application pending·0 cites
- 1247US2019060266A1Pharmaceutical compositions of tiopronin and methods for preparing thereofIMPRIMIS PHARMACEUTICALS INC·Filed 2018·Application pending·0 cites
- 1347US2016184323A1Pharmaceutical compositions for intraocular administration and methods for fabricating thereofIMPRIMIS PHARMACEUTICALS INC·Filed 2016·Application pending·0 cites
- 1446US2016045432A1Intraocular lens comprising pharmaceutical compositions and methods for fabricating thereofIMPRIMIS PHARMACEUTICALS INC·Filed 2014·Application pending·0 cites
- 1544US2018169092A1Pharmaceutical formulations for treating glaucoma and methods for fabricating and using thereofIMPRIMIS PHARMACEUTICALS INC·Filed 2017·Application pending·0 cites
- 1644US2015164882A1Pharmaceutical compositions for intraocular administration and methods for fabricating thereofIMPRIMIS PHARMACEUTICALS INC·Filed 2015·Application pending·0 cites
- 1743US2019105320A1Pharmaceutical compositions for intraocular administration and methods for fabricating thereofIMPRIMIS PHARMACEUTICALS INC·Filed 2018·Application pending·0 cites
- 1842US2017290810A1Anti-fungal compositions for treating nails and methods for fabricating and using thereofIMPRIMIS PHARMACEUTICALS INC·Filed 2017·Application pending·0 cites
- 1942US2017112936A1Pharmaceutical compositions comprising gels and methods for fabricating thereofIMPRIMIS PHARMACEUTICALS INC·Filed 2017·Application pending·0 cites
- 2041US2017172960A1Pharmaceutical formulations for treating kidney stones and methods for fabricating and using thereofIMPRIMIS PHARMACEUTICALS INC·Filed 2016·Application pending·0 cites
- 2139US2016193213A1Pharmaceutical formulations of xanthine or xanthine derivativesIMPRIMIS PHARMACEUTICALS INC·Filed 2015·Application pending·0 cites
- 2239US2016317552A1Pharmaceutical formulations for treating male sexual dysfunctionsIMPRIMIS PHARMACEUTICALS INC·Filed 2016·Application pending·0 cites
- 2338US2016243031A1Pharmaceutical ophthalmic compositions and methods for fabricating thereofIMPRIMIS PHARMACEUTICALS INC·Filed 2016·Application pending·0 cites
- 2438US2018028470A1Curcumin-based pharmaceutical compositions and methods for fabricating thereofIMPRIMIS PHARMACEUTICALS INC·Filed 2017·Application pending·0 cites
- 2536US2017165280A1Pharmaceutical formulations for treating skin disorders and methods for fabricating and using thereofIMPRIMIS PHARMACEUTICALS INC·Filed 2016·Application pending·0 cites
- 2635US9814673B2Intraocular lens comprising pharmaceutical compositions and methods for fabricating thereofIMPRIMIS PHARMACEUTICALS INC·Filed 2016·Granted Nov 14, 2017·0 cites·17 claims
- 2735US2015024996A1Pharmaceutical compositions for intraocular administration and methods for fabricating thereofIMPRIMIS PHARMACEUTICALS INC·Filed 2014·Application pending·0 cites
- 2834US2016101118A1Pharmaceutical compositions for intraocular administration and methods for fabricating thereofIMPRIMIS PHARMACEUTICALS INC·Filed 2015·Application pending·0 cites
- 2933US2016175323A1Pharmaceutical compositions for intraocular administration and methods for fabricating thereofIMPRIMIS PHARMACEUTICALS INC·Filed 2016·Application pending·0 cites
- 3032US2015129457A1Pharmaceutical compositions for intraocular administration and methods for fabricating thereofIMPRIMIS PHARMACEUTICALS INC·Filed 2015·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →